Lumen Biomedical Xtract clot buster
This article was originally published in The Gray Sheet
Executive Summary
Plymouth, Minn.-based firm announces 510(k) clearance of its aspiration catheter for removal of thrombi and soft emboli from vessels throughout the body on July 5. Xtract, which is the firm's first product to receive FDA marketing go-ahead, will be a component of the firm's FiberNet embolic protection system, currently in clinical trials...